Vinge has advised Acrinova AB (publ). Acrinova AB (publ) has executed a voluntary share redemption offering valued at approximately SEK 367.4 million. The offering, which comprised...
Acrinova Completes Voluntary Share Redemption Offering Valued at SEK 367.4 Million
Haki Safety AB Launches SEK 50 Million Rights Issue
Vinge has advised Haki Safety AB (publ). Haki Safety AB (publ) has initiated a rights issue valued at approximately SEK 50 million. The rights issue is...
Oncorena Holding AB Completes SEK 133 Million Share Issue
Vinge has advised Oncorena Holding AB. Oncorena Holding AB has conducted a share issue amounting to approximately SEK 133 million. The capital raised from the issue...
Cantargia Sells CAN10 Immunology Program to Otsuka Pharmaceutical
Vinge has advised Cantargia AB. Cantargia AB (publ) has announced the sale of its early-clinical stage IL1RAP immunology program CAN10 to Japanese healthcare company Otsuka Pharmaceutical....
EHF Invest’s Public Offer for Real Fastigheter
Vinge advised EHF Invest on the deal. EHF Invest AB has made a public offer for all shares in Real Fastigheter AB (publ). The offer values...
Trianon’s Sale of Properties
Vinge advised Trianon on the deal. Fastighets Aktiebolaget Trianon (publ) secured the sale of properties with a total agreed property value of SEK 1,062 million. Fastighets...
Pharming’s Public Offer to Abliva
Vinge advised Abliva on the deal. Pharming Technologies B.V., a wholly owned subsidiary of Pharming Group N.V., has announced a public offer to the shareholders of...
Carasent’s Listing on Nasdaq Stockholm
Vinge advised Carasent on the deal. Carasent AB (publ) completed the listing on Nasdaq Stockholm. The listing is made through a reverse cross-border merger, whereby Carasent...
Cantargia’s Rights Offering
Vinge advised Cantargia on the deal. Cantargia AB (publ) secured a rights offering of approximately SEK 170 million. Cantargia develops antibody based therapies against the target...
Trianon’s Shares Offering
Vinge advised Fastighets Aktiebolaget Trianon on the deal. Fastighets Aktiebolaget Trianon (publ) completed a directed share issue of SEK 184 million and a tender offer for...
Active Biotech’s Rights Offering
Vinge advised Active Biotech on the offering. Active Biotech AB (publ) (Nasdaq Stockholm) has carried out a rights issue of approximately SEK 51 million. Active Biotech...
Trianon’s Tender Offering
Vinge advised Fastighets Aktiebolaget Trianon on the deal. Fastighets Aktiebolaget Trianon (publ) completed a partial tender offer for outstanding subordinated perpetual floating rate callable sustainable capital...